ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

Young Takes Over Centers & Community Oncology, Says Biggest Problem Is Getting Adequate Funds

April 8, 1988

ACS announces 415 New Awards

August 31, 1979

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000